Classes
Publications
- Induced Expression of Cytochrome P450 1A and NAD(P)H:Quinone Oxidoreductase Determined at mRNA, Protein, and Enzyme Activity Levels in Rats Exposed to the Carcinogenic Azo Dye 1-Phenylazo-2-naphthol (Sudan I)2013 | Faculty of Science
- The Anticancer Drug Ellipticine Induces Cytochromes P450 1A1, 1A2 and 3A, Cytochrome b(5) and NADPH:Cytochrome P450 Oxidoreductase in Rat Liver, Kidney and Lung2013 | Faculty of Science
- Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy2011 | Faculty of Science
- Miniaturize electrochemical systems in the detection of an anticancer agents interaction with DNA2008 | Faculty of Science
- Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA2008 | Faculty of Science
- The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism2007 | Faculty of Science
- The anticancer drug ellipticine is an inducer of rat NAD(P)H : Quinone oxidoreductase2007 | Faculty of Science
- Studies with the hepatic NADPH:cytochrome P450 reductase null mouse reveal the role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine2007 | Faculty of Science
- Comparison of the cytotoxicity of and DNA adduct formation by the anticancer drug ellipticine in human breast adenocarcinoma, leukemia and neuroblastoma cells2007 | Faculty of Science
- Cytochromes P450 reconstituted with NADPH:P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes2006 | Faculty of Science
Loading network view...